Literature DB >> 29229677

Apoptotic Cancer Cells Suppress 5-Lipoxygenase in Tumor-Associated Macrophages.

Julia Ringleb1, Elisabeth Strack1, Carlo Angioni2, Gerd Geisslinger2, Dieter Steinhilber3, Andreas Weigert1, Bernhard Brüne4.   

Abstract

The enzyme 5-lipoxygenase (5-LO) is key in the synthesis of leukotrienes, which are potent proinflammatory lipid mediators involved in chronic inflammatory diseases including cancer. 5-LO is expressed in immune cells but also found in cancer cells. Although the role of 5-LO in tumor cells is beginning to emerge, with the notion that tumor-promoting functions are attributed to its products, the function of 5-LO in the tumor microenvironment remains unclear. To understand the role of 5-LO and its products in the tumor microenvironment, we analyzed its expression and function in tumor-associated macrophages (TAMs). TAMs were generated by coculturing primary human macrophages (MΦ) with human MCF-7 breast carcinoma cells, which caused cell death of cancer cells followed by phagocytosis of cell debris by MΦ. Expression and activity of 5-LO in TAMs were reduced upon coculture with cancer cells. Downregulation of 5-LO in TAMs required tumor cell death and the direct contact between MΦ and dying cancer cells via Mer tyrosine kinase. Subsequently, upregulation of proto-oncogene c-Myb in TAMs induced a stable transcriptional repression of 5-LO. Reduced 5-LO expression in TAMs was mechanistically coupled to an attenuated T cell recruitment. In primary TAMs from human and murine breast tumors, 5-LO expression was absent or low when compared with monocyte-derived MΦ. Our data reveal that 5-LO, which is required for leukotriene production and subsequent T cell recruitment, is downregulated in TAMs through Mer tyrosine kinase-dependent recognition of apoptotic cancer cells. Mechanistically, we noticed transcriptional repression of 5-LO by proto-oncogene c-Myb and conclude that loss of stromal 5-LO expression favors tumor progression.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29229677     DOI: 10.4049/jimmunol.1700609

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Lipid Metabolism in Tumor-Associated Macrophages.

Authors:  Yuancai Xiang; Hongming Miao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype.

Authors:  Ann-Christin Frank; Stefanie Ebersberger; Annika F Fink; Sebastian Lampe; Andreas Weigert; Tobias Schmid; Ingo Ebersberger; Shahzad Nawaz Syed; Bernhard Brüne
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

3.  Macrophages attenuate the transcription of CYP1A1 in breast tumor cells and enhance their proliferation.

Authors:  Sofia Winslow; Anica Scholz; Peter Rappl; Thilo F Brauß; Christina Mertens; Michaela Jung; Andreas Weigert; Bernhard Brüne; Tobias Schmid
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

4.  A new treatment for severe pulmonary arterial hypertension based on an old idea: inhibition of 5-lipoxygenase.

Authors:  Norbert F Voelkel; Marc Peters-Golden
Journal:  Pulm Circ       Date:  2020-03-26       Impact factor: 3.017

Review 5.  Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.

Authors:  Degao Chen; Xiaomei Zhang; Zhongjun Li; Bo Zhu
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 6.  Eicosanoids in Cancer: New Roles in Immunoregulation.

Authors:  Amber M Johnson; Emily K Kleczko; Raphael A Nemenoff
Journal:  Front Pharmacol       Date:  2020-11-18       Impact factor: 5.810

7.  Neomenthol prevents the proliferation of skin cancer cells by restraining tubulin polymerization and hyaluronidase activity.

Authors:  Kaneez Fatima; Nusrat Masood; Zahoor Ahmad Wani; Abha Meena; Suaib Luqman
Journal:  J Adv Res       Date:  2021-06-10       Impact factor: 10.479

8.  Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer.

Authors:  Poonam Sarode; Xiang Zheng; Georgia A Giotopoulou; Andreas Weigert; Carste Kuenne; Stefan Günther; Aleksandra Friedrich; Stefan Gattenlöhner; Thorsten Stiewe; Bernhard Brüne; Friedrich Grimminger; Georgios T Stathopoulos; Soni Savai Pullamsetti; Werner Seeger; Rajkumar Savai
Journal:  Sci Adv       Date:  2020-06-05       Impact factor: 14.136

Review 9.  Specialized Pro-Resolving Mediators Mitigate Cancer-Related Inflammation: Role of Tumor-Associated Macrophages and Therapeutic Opportunities.

Authors:  Margot Lavy; Vanessa Gauttier; Nicolas Poirier; Sophie Barillé-Nion; Christophe Blanquart
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.